PDB Short entry for 2W3B HEADER OXIDOREDUCTASE 11-NOV-08 2W3B TITLE HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC TITLE 2 ANTIFOLATE SELECTIVE FOR MYCOBACTERIUM AVIUM DHFR, 6-((2,5- TITLE 3 DIETHOXYPHENYL)AMINOMETHYL)-2,4-DIAMINO-5-METHYLPYRIDO(2,3-D) TITLE 4 PYRIMIDINE (SRI-8686) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET11A; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PDFR KEYWDS NONCLASSICAL ANTIFOLATES, ONE-CARBON METABOLISM, LIPOPHILIC KEYWDS 2 ANTIFOLATES, NADP, REDUCTASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR A.K.W.LEUNG,R.C.REYNOLDS,D.W.BORHANI REVDAT 3 08-MAY-19 2W3B 1 REMARK REVDAT 2 06-MAR-19 2W3B 1 REMARK REVDAT 1 17-NOV-09 2W3B 0 JRNL AUTH A.K.W.LEUNG,L.J.ROSS,S.ZYWNO-VAN GINKEL,R.C.REYNOLDS, JRNL AUTH 2 L.E.SEITZ,V.PATHAK,W.W.BARROW,E.L.WHITE,W.J.SULING, JRNL AUTH 3 J.R.PIPER,D.W.BORHANI JRNL TITL STRUCTURAL BASIS FOR SELECTIVE INHIBITION OF MYCOBACTERIUM JRNL TITL 2 AVIUM DIHYDROFOLATE REDUCTASE BY A LIPOPHILIC ANTIFOLATE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 98560 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 5251 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.27 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.30 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7090 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2600 REMARK 3 BIN FREE R VALUE SET COUNT : 407 REMARK 3 BIN FREE R VALUE : 0.2950 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2917 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 216 REMARK 3 SOLVENT ATOMS : 573 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.23000 REMARK 3 B22 (A**2) : 0.46000 REMARK 3 B33 (A**2) : -0.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.054 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.052 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.037 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.906 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.963 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3374 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2317 ; 0.005 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4618 ; 1.648 ; 2.050 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5648 ; 1.228 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 405 ; 6.151 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 130 ;36.887 ;24.923 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 559 ;11.058 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;10.274 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 482 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3699 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 619 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 595 ; 0.225 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2413 ; 0.205 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1602 ; 0.183 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1627 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 346 ; 0.149 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 11 ; 0.231 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 56 ; 0.253 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 77 ; 0.143 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1974 ; 1.275 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3233 ; 1.950 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1432 ; 2.768 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1385 ; 3.718 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 4 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 185 REMARK 3 RESIDUE RANGE : A 201 A 201 REMARK 3 RESIDUE RANGE : A 301 A 301 REMARK 3 RESIDUE RANGE : A 401 A 401 REMARK 3 ORIGIN FOR THE GROUP (A): 0.6120 23.9080 -1.1710 REMARK 3 T TENSOR REMARK 3 T11: -0.0388 T22: -0.0334 REMARK 3 T33: -0.0318 T12: -0.0161 REMARK 3 T13: -0.0101 T23: 0.0005 REMARK 3 L TENSOR REMARK 3 L11: 1.1050 L22: 0.8013 REMARK 3 L33: 0.9024 L12: 0.1095 REMARK 3 L13: -0.0592 L23: 0.1211 REMARK 3 S TENSOR REMARK 3 S11: -0.0038 S12: -0.0632 S13: -0.0420 REMARK 3 S21: 0.0910 S22: -0.0200 S23: -0.0174 REMARK 3 S31: 0.0546 S32: -0.0127 S33: 0.0238 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 4 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 186 REMARK 3 RESIDUE RANGE : B 201 B 201 REMARK 3 RESIDUE RANGE : B 301 B 301 REMARK 3 RESIDUE RANGE : B 401 B 401 REMARK 3 ORIGIN FOR THE GROUP (A): 20.9470 45.2080 22.6730 REMARK 3 T TENSOR REMARK 3 T11: -0.0066 T22: -0.0334 REMARK 3 T33: -0.0693 T12: 0.0594 REMARK 3 T13: -0.0036 T23: -0.0251 REMARK 3 L TENSOR REMARK 3 L11: 1.2455 L22: 1.3847 REMARK 3 L33: 1.7082 L12: -0.2111 REMARK 3 L13: 0.0155 L23: 0.1525 REMARK 3 S TENSOR REMARK 3 S11: -0.1546 S12: -0.2329 S13: 0.0679 REMARK 3 S21: 0.1145 S22: 0.0608 S23: -0.0567 REMARK 3 S31: 0.0384 S32: -0.0904 S33: 0.0938 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2W3B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1290038071. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.785 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 109188 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -10.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.71000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: UNPUBLISHED HUMAN DHFR FOLATE COMPLEX REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HUMAN DHFR/FOLATE COMPLEX WAS MIXED REMARK 280 WITH NADPH AND 6-((2,5-DIETHOXYPHENYL)AMINOMETHYL)-2, 4-DIAMINO- REMARK 280 5-METHYLPYRIDO(2,3-D)PYRIMIDINE (SRI-8686) (BOTH 2 MM FINAL). REMARK 280 CRYSTALS WERE GROWN BY HANGING DROP VAPOR DIFFUSION AT 277 K BY REMARK 280 MIXING EQUAL VOLUMES OF PROTEIN/NADPH/SRI-8686 WITH RESERVOIR REMARK 280 (24% PEG 4000, 200 MM LI2SO4, 100 MM TRIS.HCL, PH 8.75). REMARK 280 TRUNCATED TRIANGULAR CRYSTALS APPEARED SLOWLY, IN ABOUT A MONTH. REMARK 280 THE CRYSTAL WAS CRYOPROTECTED WITH 15% GLYCEROL AND FLASH-COOLED REMARK 280 IN LIQUID N2., VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.71950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.71950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.86250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.19350 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.86250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.19350 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 47.71950 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.86250 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.19350 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 47.71950 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.86250 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.19350 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2263 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ASP A 186 REMARK 465 MET B 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 84 CD OE1 NE2 REMARK 470 ARG A 91 CD NE CZ NH1 NH2 REMARK 470 LYS A 98 CG CD CE NZ REMARK 470 GLU A 101 CD OE1 OE2 REMARK 470 LYS A 108 CD CE NZ REMARK 470 GLU A 150 CG CD OE1 OE2 REMARK 470 LYS A 157 CD CE NZ REMARK 470 ARG B 28 CD NE CZ NH1 NH2 REMARK 470 ARG B 32 NE CZ NH1 NH2 REMARK 470 GLU B 44 CG CD OE1 OE2 REMARK 470 LYS B 63 CD CE NZ REMARK 470 LYS B 68 CE NZ REMARK 470 ARG B 77 NE CZ NH1 NH2 REMARK 470 GLU B 78 CD OE1 OE2 REMARK 470 GLU B 81 CD OE1 OE2 REMARK 470 GLN B 84 CD OE1 NE2 REMARK 470 GLU B 123 CD OE1 OE2 REMARK 470 GLU B 150 CG CD OE1 OE2 REMARK 470 LYS B 155 CE NZ REMARK 470 LYS B 157 CD CE NZ REMARK 470 GLU B 161 CD OE1 OE2 REMARK 470 ASP B 186 C O CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS B 132 OH TYR B 162 2.00 REMARK 500 O LEU A 79 O HOH A 2160 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 80 -103.17 116.66 REMARK 500 ASP A 110 -96.19 -94.84 REMARK 500 MET A 139 48.71 -89.48 REMARK 500 MET A 139 48.71 -85.78 REMARK 500 ASP B 110 -94.58 -94.32 REMARK 500 MET B 139 41.26 -86.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2010 DISTANCE = 6.44 ANGSTROMS REMARK 525 HOH A2024 DISTANCE = 6.29 ANGSTROMS REMARK 525 HOH A2184 DISTANCE = 7.13 ANGSTROMS REMARK 525 HOH B2009 DISTANCE = 6.61 ANGSTROMS REMARK 525 HOH B2116 DISTANCE = 6.19 ANGSTROMS REMARK 525 HOH B2217 DISTANCE = 8.33 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 6-((2,5-DIETHOXYPHENYL)AMINOMETHYL)-2, REMARK 600 4-DIAMINO-5-METHYLPYRIDO(2,3-D)PYRIMIDINE (VG9): SRI-8686 REMARK 600 FOLIC ACID (FOL): FOLATE REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 K A 501 K REMARK 620 N RES CSSEQI ATOM REMARK 620 1 VAL A 43 O REMARK 620 2 SER A 41 O 112.7 REMARK 620 3 SER A 41 OG 81.0 65.0 REMARK 620 4 LYS A 46 O 81.9 147.5 90.5 REMARK 620 5 HOH A2111 O 157.1 84.1 93.2 75.9 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 K B 501 K REMARK 620 N RES CSSEQI ATOM REMARK 620 1 VAL B 43 O REMARK 620 2 LYS B 46 O 81.0 REMARK 620 3 HOH B2078 O 94.4 175.2 REMARK 620 4 HOH B2089 O 150.1 78.9 104.9 REMARK 620 5 SER B 41 OG 65.0 77.5 99.4 89.1 REMARK 620 N 1 2 3 4 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VG9 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FOL A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VG9 B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FOL B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2W3A RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM REMARK 900 RELATED ID: 2C2S RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2,4-DIAMINO- REMARK 900 5-(1-O- CARBORANYLMETHYL)-6-METHYLPYRIMIDINE, A NOVEL BORON REMARK 900 CONTANING, NONCLASSICAL ANTIFOLATE REMARK 900 RELATED ID: 2W3M RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND FOLATE REMARK 900 RELATED ID: 1DHF RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE (DHFR) COMPLEX WITH FOLATE REMARK 900 RELATED ID: 2DHF RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE (DHFR) COMPLEX WITH 5 -DEAZAFOLATE REMARK 900 RELATED ID: 1S3W RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINEANTIFOALTES IN REMARK 900 COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINIIDIHYDROFOLATE REDUCTASE: REMARK 900 CORRELATIONS OF ENZYMESELECTIVITY AND STEREOCHEMISTRY REMARK 900 RELATED ID: 1S3V RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINEANTIFOLATES IN REMARK 900 COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINIIDIHYDROFOLATE REDUCTASE: REMARK 900 CORRELATIONS OF ENZYMESELECTIVITY AND STEREOCHEMISTRY REMARK 900 RELATED ID: 1PD8 RELATED DB: PDB REMARK 900 ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5-METHYL-6- REMARK 900 N- METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATECOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1DLS RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE (DHFR) MUTANT WITH LEU 22 REPLACED BY TYR REMARK 900 (L22Y) COMPLEXED WITH NADPH AND METHOTREXATE REMARK 900 RELATED ID: 1DLR RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE (DHFR) MUTANT WITH LEU 22 REPLACED BY PHE REMARK 900 (L22F) COMPLEXED WITH NADPH AND PIRITREXIM (PTX) REMARK 900 RELATED ID: 1U72 RELATED DB: PDB REMARK 900 UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATERESISTANCE: REMARK 900 COMPARISON OF WILD- TYPE AND LEU22ARG VARIANTMOUSE AND HUMAN REMARK 900 DIHYDRFOLATE REDUCTASE TERNARY CRYSTALCOMPLEXES WITH METHOTREXATE REMARK 900 AND NADPH REMARK 900 RELATED ID: 1OHK RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE, ORTHORHOMBIC (P21 21 21) CRYSTAL FORM REMARK 900 RELATED ID: 1YHO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASECOMPLEXED WITH REMARK 900 TRIMETHOPRIM AND NADPH , 25 STRUCTURES REMARK 900 RELATED ID: 2C2T RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2,4-DIAMINO- REMARK 900 5-((7,8- DICARBAUNDECABORAN-7-YL)METHYL)-6- METHYLPYRIMIDINE, A REMARK 900 NOVEL BORON CONTANING, NONCLASSICAL ANTIFOLATE REMARK 900 RELATED ID: 1OHJ RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE, MONOCLINIC (P21 ) CRYSTAL FORM REMARK 900 RELATED ID: 1PD9 RELATED DB: PDB REMARK 900 ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5-METHYL-6- REMARK 900 N- METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATECOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1KMV RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (Z)-6-(2-[2, REMARK 900 5-DIMETHOXYPHENYL] ETHEN-1-YL)-2,4-DIAMINO-5-METHYLPYRIDO[2 ,3-D] REMARK 900 PYRIMIDINE (SRI-9662), A LIPOPHILICANTIFOLATE REMARK 900 RELATED ID: 1HFR RELATED DB: PDB REMARK 900 COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REMARK 900 REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE REMARK 900 RELATED ID: 1MVT RELATED DB: PDB REMARK 900 ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[2,3-D]PYRIMIDINE N9- REMARK 900 C10 REVERSE- BRIDGE ANTIFOLATE BINARYCOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1U71 RELATED DB: PDB REMARK 900 UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATERESISTANCE: REMARK 900 COMPARISON OF WILD- TYPE AND LEU22ARG VARIANTMOUSE AND HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE TERNARY CRYSTALCOMPLEXES WITH METHOTREXATE REMARK 900 AND NADPH REMARK 900 RELATED ID: 1KMS RELATED DB: PDB REMARK 900 HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-([5- REMARK 900 QUINOLYLAMINO]METHYL)-2,4 -DIAMINO-5-METHYLPYRIDO[2,3-D]PYRIMIDINE REMARK 900 ( SRI-9439), A LIPOPHILIC ANTIFOLATE REMARK 900 RELATED ID: 1PDB RELATED DB: PDB REMARK 900 ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5-METHYL-6- REMARK 900 N- METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATECOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1HFQ RELATED DB: PDB REMARK 900 COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REMARK 900 REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE REMARK 900 RELATED ID: 1MVS RELATED DB: PDB REMARK 900 ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[2,3-D]PYRIMIDINE N9- REMARK 900 C10 REVERSE- BRIDGE ANTIFOLATE BINARYCOMPLEX WITH HUMAN REMARK 900 DIHYDROFOLATE REDUCTASE REMARK 900 RELATED ID: 1DRF RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE COMPLEX WITH FOLATE REMARK 900 RELATED ID: 1S3U RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINEANTIFOLATES IN REMARK 900 COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINIIDIHYDROFOLATE REDUCTASE: REMARK 900 CORRELATIONS OF ENZYMESELECTIVITY AND STEREOCHEMISTRY REMARK 900 RELATED ID: 1HFP RELATED DB: PDB REMARK 900 COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REMARK 900 REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE REMARK 900 RELATED ID: 1BOZ RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN AND SYNTHESIS OF LIPOPHILIC 2,4- DIAMINO-6- REMARK 900 SUBSTITUTED QUINAZOLINES AND THEIR EVALUATION AS INHIBITORS OF REMARK 900 DIHYDROFOLATE REDUCTASE AND POTENTIAL ANTITUMOR AGENTS DBREF 2W3B A 0 186 UNP P00374 DYR_HUMAN 1 187 DBREF 2W3B B 0 186 UNP P00374 DYR_HUMAN 1 187 SEQRES 1 A 187 MET VAL GLY SER LEU ASN CYS ILE VAL ALA VAL SER GLN SEQRES 2 A 187 ASN MET GLY ILE GLY LYS ASN GLY ASP LEU PRO TRP PRO SEQRES 3 A 187 PRO LEU ARG ASN GLU PHE ARG TYR PHE GLN ARG MET THR SEQRES 4 A 187 THR THR SER SER VAL GLU GLY LYS GLN ASN LEU VAL ILE SEQRES 5 A 187 MET GLY LYS LYS THR TRP PHE SER ILE PRO GLU LYS ASN SEQRES 6 A 187 ARG PRO LEU LYS GLY ARG ILE ASN LEU VAL LEU SER ARG SEQRES 7 A 187 GLU LEU LYS GLU PRO PRO GLN GLY ALA HIS PHE LEU SER SEQRES 8 A 187 ARG SER LEU ASP ASP ALA LEU LYS LEU THR GLU GLN PRO SEQRES 9 A 187 GLU LEU ALA ASN LYS VAL ASP MET VAL TRP ILE VAL GLY SEQRES 10 A 187 GLY SER SER VAL TYR LYS GLU ALA MET ASN HIS PRO GLY SEQRES 11 A 187 HIS LEU LYS LEU PHE VAL THR ARG ILE MET GLN ASP PHE SEQRES 12 A 187 GLU SER ASP THR PHE PHE PRO GLU ILE ASP LEU GLU LYS SEQRES 13 A 187 TYR LYS LEU LEU PRO GLU TYR PRO GLY VAL LEU SER ASP SEQRES 14 A 187 VAL GLN GLU GLU LYS GLY ILE LYS TYR LYS PHE GLU VAL SEQRES 15 A 187 TYR GLU LYS ASN ASP SEQRES 1 B 187 MET VAL GLY SER LEU ASN CYS ILE VAL ALA VAL SER GLN SEQRES 2 B 187 ASN MET GLY ILE GLY LYS ASN GLY ASP LEU PRO TRP PRO SEQRES 3 B 187 PRO LEU ARG ASN GLU PHE ARG TYR PHE GLN ARG MET THR SEQRES 4 B 187 THR THR SER SER VAL GLU GLY LYS GLN ASN LEU VAL ILE SEQRES 5 B 187 MET GLY LYS LYS THR TRP PHE SER ILE PRO GLU LYS ASN SEQRES 6 B 187 ARG PRO LEU LYS GLY ARG ILE ASN LEU VAL LEU SER ARG SEQRES 7 B 187 GLU LEU LYS GLU PRO PRO GLN GLY ALA HIS PHE LEU SER SEQRES 8 B 187 ARG SER LEU ASP ASP ALA LEU LYS LEU THR GLU GLN PRO SEQRES 9 B 187 GLU LEU ALA ASN LYS VAL ASP MET VAL TRP ILE VAL GLY SEQRES 10 B 187 GLY SER SER VAL TYR LYS GLU ALA MET ASN HIS PRO GLY SEQRES 11 B 187 HIS LEU LYS LEU PHE VAL THR ARG ILE MET GLN ASP PHE SEQRES 12 B 187 GLU SER ASP THR PHE PHE PRO GLU ILE ASP LEU GLU LYS SEQRES 13 B 187 TYR LYS LEU LEU PRO GLU TYR PRO GLY VAL LEU SER ASP SEQRES 14 B 187 VAL GLN GLU GLU LYS GLY ILE LYS TYR LYS PHE GLU VAL SEQRES 15 B 187 TYR GLU LYS ASN ASP HET NDP A 201 48 HET VG9 A 301 27 HET FOL A 401 32 HET K A 501 1 HET NDP B 201 48 HET VG9 B 301 27 HET FOL B 401 32 HET K B 501 1 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM VG9 6-{[(2,5-DIETHOXYPHENYL)AMINO]METHYL}-5-METHYLPYRIDO[2, HETNAM 2 VG9 3-D]PYRIMIDINE-2,4-DIAMINE HETNAM FOL FOLIC ACID HETNAM K POTASSIUM ION FORMUL 3 NDP 2(C21 H30 N7 O17 P3) FORMUL 4 VG9 2(C19 H24 N6 O2) FORMUL 5 FOL 2(C19 H19 N7 O6) FORMUL 6 K 2(K 1+) FORMUL 11 HOH *573(H2 O) HELIX 1 1 LEU A 27 THR A 40 1 14 HELIX 2 2 LYS A 54 ILE A 60 1 7 HELIX 3 3 PRO A 61 ARG A 65 5 5 HELIX 4 4 SER A 92 THR A 100 1 9 HELIX 5 5 GLY A 117 ASN A 126 1 10 HELIX 6 6 LEU B 27 THR B 40 1 14 HELIX 7 7 LYS B 54 ILE B 60 1 7 HELIX 8 8 PRO B 61 ARG B 65 5 5 HELIX 9 9 SER B 92 THR B 100 1 9 HELIX 10 10 GLY B 117 ASN B 126 1 10 SHEET 1 AA 8 PHE A 88 SER A 90 0 SHEET 2 AA 8 ILE A 71 LEU A 75 1 O ASN A 72 N PHE A 88 SHEET 3 AA 8 GLN A 47 GLY A 53 1 O ASN A 48 N ILE A 71 SHEET 4 AA 8 VAL A 109 ILE A 114 1 N ASP A 110 O GLN A 47 SHEET 5 AA 8 SER A 3 VAL A 10 1 O ASN A 5 N ILE A 114 SHEET 6 AA 8 HIS A 130 ILE A 138 1 O HIS A 130 N LEU A 4 SHEET 7 AA 8 ILE A 175 LYS A 184 -1 O LYS A 178 N ARG A 137 SHEET 8 AA 8 LYS A 157 LEU A 158 -1 O LYS A 157 N GLU A 183 SHEET 1 AB 7 PHE A 88 SER A 90 0 SHEET 2 AB 7 ILE A 71 LEU A 75 1 O ASN A 72 N PHE A 88 SHEET 3 AB 7 GLN A 47 GLY A 53 1 O ASN A 48 N ILE A 71 SHEET 4 AB 7 VAL A 109 ILE A 114 1 N ASP A 110 O GLN A 47 SHEET 5 AB 7 SER A 3 VAL A 10 1 O ASN A 5 N ILE A 114 SHEET 6 AB 7 HIS A 130 ILE A 138 1 O HIS A 130 N LEU A 4 SHEET 7 AB 7 ILE A 175 LYS A 184 -1 O LYS A 178 N ARG A 137 SHEET 1 AC 2 GLY A 15 GLY A 17 0 SHEET 2 AC 2 THR A 146 PHE A 147 -1 O THR A 146 N ILE A 16 SHEET 1 BA 8 PHE B 88 SER B 90 0 SHEET 2 BA 8 ARG B 70 LEU B 75 1 O ASN B 72 N PHE B 88 SHEET 3 BA 8 GLN B 47 GLY B 53 1 O ASN B 48 N ILE B 71 SHEET 4 BA 8 VAL B 109 ILE B 114 1 N ASP B 110 O GLN B 47 SHEET 5 BA 8 SER B 3 SER B 11 1 O ASN B 5 N ILE B 114 SHEET 6 BA 8 HIS B 130 ILE B 138 1 O HIS B 130 N LEU B 4 SHEET 7 BA 8 ILE B 175 LYS B 184 -1 O LYS B 178 N ARG B 137 SHEET 8 BA 8 LYS B 157 LEU B 158 -1 O LYS B 157 N GLU B 183 SHEET 1 BB 7 PHE B 88 SER B 90 0 SHEET 2 BB 7 ARG B 70 LEU B 75 1 O ASN B 72 N PHE B 88 SHEET 3 BB 7 GLN B 47 GLY B 53 1 O ASN B 48 N ILE B 71 SHEET 4 BB 7 VAL B 109 ILE B 114 1 N ASP B 110 O GLN B 47 SHEET 5 BB 7 SER B 3 SER B 11 1 O ASN B 5 N ILE B 114 SHEET 6 BB 7 HIS B 130 ILE B 138 1 O HIS B 130 N LEU B 4 SHEET 7 BB 7 ILE B 175 LYS B 184 -1 O LYS B 178 N ARG B 137 SHEET 1 BC 2 GLY B 15 GLY B 17 0 SHEET 2 BC 2 THR B 146 PHE B 147 -1 O THR B 146 N ILE B 16 LINK K K A 501 O VAL A 43 1555 1555 2.74 LINK K K A 501 O SER A 41 1555 1555 2.84 LINK K K A 501 OG SER A 41 1555 1555 3.16 LINK K K A 501 O LYS A 46 1555 1555 2.71 LINK K K A 501 O HOH A2111 1555 1555 2.95 LINK K K B 501 O VAL B 43 1555 1555 2.81 LINK K K B 501 O LYS B 46 1555 1555 2.59 LINK K K B 501 O HOH B2078 1555 1555 2.93 LINK K K B 501 O HOH B2089 1555 1555 2.77 LINK K K B 501 OG SER B 41 1555 1555 3.08 CISPEP 1 ARG A 65 PRO A 66 0 -7.22 CISPEP 2 LEU A 79 LYS A 80 0 3.48 CISPEP 3 GLY A 116 GLY A 117 0 4.19 CISPEP 4 ARG B 65 PRO B 66 0 -7.69 CISPEP 5 GLY B 116 GLY B 117 0 5.60 SITE 1 AC1 35 VAL A 8 ALA A 9 ILE A 16 GLY A 17 SITE 2 AC1 35 LYS A 18 GLY A 20 ASP A 21 LEU A 22 SITE 3 AC1 35 GLY A 53 LYS A 54 LYS A 55 THR A 56 SITE 4 AC1 35 LEU A 75 SER A 76 ARG A 77 GLU A 78 SITE 5 AC1 35 ARG A 91 VAL A 115 GLY A 117 SER A 118 SITE 6 AC1 35 SER A 119 VAL A 120 TYR A 121 THR A 146 SITE 7 AC1 35 VG9 A 301 FOL A 401 HOH A2134 HOH A2209 SITE 8 AC1 35 HOH A2234 HOH A2300 HOH A2302 HOH A2303 SITE 9 AC1 35 HOH A2304 HOH A2305 HOH A2306 SITE 1 AC2 16 ILE A 7 VAL A 8 ALA A 9 ASP A 21 SITE 2 AC2 16 LEU A 22 GLU A 30 PHE A 31 PHE A 34 SITE 3 AC2 16 GLN A 35 SER A 59 PRO A 61 ASN A 64 SITE 4 AC2 16 VAL A 115 TYR A 121 NDP A 201 HOH A2305 SITE 1 AC3 19 ILE A 7 VAL A 8 ALA A 9 GLU A 30 SITE 2 AC3 19 PHE A 31 ARG A 32 PHE A 34 GLN A 35 SITE 3 AC3 19 ILE A 60 ASN A 64 LEU A 67 ARG A 70 SITE 4 AC3 19 VAL A 115 THR A 136 NDP A 201 HOH A2305 SITE 5 AC3 19 HOH A2308 HOH A2309 HOH A2310 SITE 1 AC4 4 SER A 41 VAL A 43 LYS A 46 HOH A2111 SITE 1 AC5 30 VAL B 8 ALA B 9 ILE B 16 GLY B 17 SITE 2 AC5 30 ASP B 21 LEU B 22 GLY B 53 LYS B 54 SITE 3 AC5 30 LYS B 55 THR B 56 SER B 59 LEU B 75 SITE 4 AC5 30 SER B 76 ARG B 77 GLU B 78 ARG B 91 SITE 5 AC5 30 VAL B 115 GLY B 117 SER B 118 SER B 119 SITE 6 AC5 30 VAL B 120 TYR B 121 THR B 146 VG9 B 301 SITE 7 AC5 30 FOL B 401 HOH B2159 HOH B2186 HOH B2264 SITE 8 AC5 30 HOH B2265 HOH B2266 SITE 1 AC6 16 ILE B 7 VAL B 8 ALA B 9 GLU B 30 SITE 2 AC6 16 PHE B 31 PHE B 34 PRO B 61 LEU B 67 SITE 3 AC6 16 ARG B 70 VAL B 115 TYR B 121 NDP B 201 SITE 4 AC6 16 HOH B2012 HOH B2038 HOH B2264 HOH B2267 SITE 1 AC7 18 ILE B 7 VAL B 8 ALA B 9 GLU B 30 SITE 2 AC7 18 PHE B 31 ARG B 32 PHE B 34 GLN B 35 SITE 3 AC7 18 ILE B 60 ASN B 64 LEU B 67 ARG B 70 SITE 4 AC7 18 VAL B 115 THR B 136 NDP B 201 HOH B2047 SITE 5 AC7 18 HOH B2264 HOH B2268 SITE 1 AC8 5 SER B 41 VAL B 43 LYS B 46 HOH B2078 SITE 2 AC8 5 HOH B2089 CRYST1 87.725 94.387 95.439 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011399 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010595 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010478 0.00000 MTRIX1 1 -0.074950 0.996292 -0.042240 -2.61422 1 MTRIX2 1 -0.994802 -0.077632 -0.065899 47.67767 1 MTRIX3 1 -0.068934 0.037081 0.996932 22.85954 1